Patients Mainly Prefer AI as Second Reader for Screening Mammogram

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, April 23, 2025 -- Use of artificial intelligence (AI) as a second reader in screening mammography is accepted by patients, according to a study published online April 18 in Radiology: Imaging Cancer.

B. Bersu Ozcan, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues conducted a prospective study involving 518 patients undergoing mammography screening between February and August 2023 who were offered a 29-question survey. Independent factors associated with participants' acceptance of AI use were examined.

The researchers found that 76.5 percent of participants reported no or minimal knowledge of AI. Overall, 4.44 percent accepted stand-alone AI interpretation, while 71.0 percent preferred AI to be used as a second reader. Most participants (88.9 percent) requested radiologist review after an AI-reported abnormality, compared with 51.3 percent who requested radiologist recall review by AI. A higher number of participants would undergo diagnostic examination for radiologist recalls versus AI recalls in cases of discrepancy, although the difference was not significant (94.2 versus 92.6 percent). Greater AI acceptance was seen in association with higher education (odds ratio, 2.05). Concern for bias was seen in association with race and was higher in Hispanic and non-Hispanic Black versus non-Hispanic White participants (odds ratios, 3.32 and 4.31, respectively).

"Our results indicate a cautious optimism among participants about the integration of AI in mammogram interpretation," the authors write.

One author disclosed ties to the publishing and medical device industries and holds a related patent.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-04-24 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords